AnX Robotica
AnX Robotica is a Plano, Texas-based medical device company that develops the NaviCam platform of magnetically controlled capsule endoscopy systems and AI-assisted reading software (ProScan) for non-invasive gastrointestinal diagnosis, serving gastroenterologists, hospitals, and ambulatory surgery centers globally.
- Company typePrivate
- Founded2019
- HeadquartersPlano, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What AnX Robotica does
AnX Robotica is a Plano, Texas-based medical device company founded in 2019 that develops and commercializes the NaviCam GI Diagnostic Platform, a portfolio of magnetically controlled capsule endoscopy (MCCE) systems, AI-assisted reading software, and consumable capsule products for non-invasive gastrointestinal diagnosis. The company's technology, originating from its commercial partnership with ANKON Medical Technologies (founded 2009), enables physicians to remotely visualize the esophagus, stomach, small bowel, and colon using disposable ingestible capsules rather than conventional sedated endoscopy. The flagship NaviCam SB system is paired with ProScan, the first FDA-cleared AI-assisted reading tool for small bowel video capsule endoscopy, and the company has since expanded into motility monitoring with MotiliCap/MotiliScan (FDA-cleared May 2025, positioned as a SmartPill replacement) and esophageal visualization with NaviCam T/XST.
The company generates revenue through sales of capital equipment systems, recurring single-use capsule consumables, and software licenses (ProScan, MotiliScan, ESView). It operates a hybrid go-to-market model combining a direct US sales force of 25+ regional account managers with an international distributor network spanning 22+ countries across EMEA, APAC, and LATAM, and has secured a national group purchasing agreement with Premier, Inc. effective February 2025. Target customers include gastroenterologists, hospitals, ambulatory surgery centers, and pediatric GI practices. AnX Robotica is privately held with no disclosed institutional funding rounds; ownership is associated with founding management and ANKON-related stakeholders. The company reports 900+ systems installed globally and 600,000+ patient procedures performed, with active expansion evidenced by FDA clearances in 2024–2025, leadership appointments, and new product launches at DDW 2025.
AnX Robotica firmographics
Firmographics- Name
- AnX Robotica
- Legal name
- AnX Robotica Corp.
- Website
- https://anxrobotics.com
- Company type
- Private
- Founded year
- 2019
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- AnX Robotica is a Plano, Texas-based medical device company that develops the NaviCam platform of magnetically controlled capsule endoscopy systems and AI-assisted reading software (ProScan) for non-invasive gastrointestinal diagnosis, serving gastroenterologists, hospitals, and ambulatory surgery centers globally.
- Ownership category
- akta.pro rank
AnX Robotica industry classification
Industry- Product category
- Medical Devices - Capsule Endoscopy Systems
- NAICS
- Surgical and Medical Instrument Manufacturing (339112), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Endoscopy Systems & Accessories (Scopes, Cameras, Light Sources, Insufflation) (HLAHADAB)
Keywords
Where AnX Robotica is headquartered
LocationHeadquarters
- HQ city
- Plano
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
AnX Robotica business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Supply Chain, Marketing or Sales, Operations, Infrastructure
Revenue model
- Capsule Endoscopy Systems: AnX Robotica generates revenue through the sale of its capsule endoscopy systems including NaviCam SB, NaviCam Stomach, and related software platforms. The company sells hardware systems along with disposable capsules and software licenses to healthcare providers including hospitals, endoscopy centers, and gastroenterology practices.
- Disposable Capsules: Single-use capsule devices for procedures including small bowel capsule endoscopy, motility capsules, and esophageal visualization - recurring consumable revenue from healthcare providers
- Software Subscriptions: ProScan AI software and MotiliScan companion software platforms may generate recurring software licensing revenue for interpretation and analysis services
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Quote-based pricing through Premier GPO agreement |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels6 records
AnX Robotica product offering
Product offeringCore offering
AnX Robotica designs, manufactures, and commercializes magnetically controlled capsule endoscopy systems, AI-assisted diagnostic software, and single-use GI capsules that enable non-invasive, sedation-free visualization of the esophagus, stomach, small bowel, and colon. Its NaviCam platform combines proprietary magnetic-control hardware, deep learning image analysis (ProScan), and clinical software (ESView, MotiliScan) to deliver complete gastrointestinal diagnostic workflows to gastroenterologists, hospitals, and ambulatory surgery centers. The company also sells disposable capsules and radiopaque markers (IntraMarX) that drive recurring consumable revenue.
Product overview
AnX Robotica offers a platform-based portfolio centered on the NaviCam GI Diagnostic Platform. The core offering includes magnetically controlled capsule endoscopy (MCCE) systems for stomach, esophageal, and small bowel visualization, supplemented by AI-assisted reading (ProScan) and software platforms (ESView, MotiliScan). The product line spans: NaviCam Small Bowel with ProScan (the first FDA-cleared AI-assisted reading tool for VCE), NaviCam T/XST tethered capsules for esophageal visualization, NaviCam Xpress MCCE for stomach evaluation, NaviCam Colon System (available in Europe), MotiliCap and MotiliScan for whole-gut motility monitoring, and IntraMarX radiopaque markers for colonic transit studies. The company positions its NaviCam platform as a comprehensive GI diagnostic ecosystem.
Differentiator
Problem solved
Functional benefit
Brands
- NaviCam Platform: Comprehensive suite of advanced technologies for gastrointestinal diagnostics including capsule endoscopy systems.
- ProScan
- MotiliScan
- ESView
Products and services
- NaviCam SB System with ProScan Small bowel video capsule endoscopy system with FDA-cleared AI-assisted reading tool (ProScan). Uses aspherical lens technology to reduce distortion and enhance field of vision, delivering AI-assisted interpretation in approximately 4 minutes with exceptional sensitivity and specificity for adult and pediatric (2+ years) patients with suspected small bowel bleeding.
- NaviCam XS Next-generation small bowel capsule that is 44% smaller by volume than standard capsules, designed for enhanced patient comfort and easier ingestion without compromising image quality or diagnostic reliability.
- NaviCam T / NaviCam XST Tethered Capsule System Tethered capsule system for real-time esophageal visualization without sedation. The XST variant offers optimized patient experience with a smaller, more comfortable capsule. Features ESView RT Display for instant image capture and navigation during esophageal procedures.
- MotiliCap with MotiliScan Wireless single-use motility capsule that measures pH, pressure, and temperature for comprehensive whole-gut transit assessment, evaluating gastric emptying through colonic transit without sedation, imaging, or radiation. Includes MotiliScan companion software for data visualization and advanced analytics with customizable reporting, segment-specific analysis, and automated summaries. Designed to replace discontinued SmartPill technology.
- NaviCam Xpress Stomach System Magnetically controlled capsule endoscopy system for precise, non-invasive stomach evaluation. Enables complete gastric assessment in 20 minutes with real-time visualization and physician-directed magnetic navigation inside the stomach, all without sedation.
- NaviCam Colon System Capsule endoscopy system offering complete, non-invasive view of the colon with high-resolution imaging, requiring no sedation, radiation, or traditional endoscopy. Currently available outside the United States only.
- IntraMarX / IntraMarX 3D Radiopaque Markers Capsule-based diagnostic tool containing 24 tiny radiopaque rings visible via X-ray for accurate colonic transit assessment. Used to diagnose chronic constipation, colonic inertia, and functional outlet delay.
Quantifiable outcome
- Reading time reduced to approximately 4 minutes with ProScan AI-assisted reading
- +4 more outcomes
Companies that use AnX Robotica
Customer profileNamed customers4 records
Segments4 records
Ideal customer profiles5 records
AnX Robotica technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability4 records
Feature6 records
AnX Robotica partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core.
- Premier, Inc.coreAnX Robotica was awarded a national group purchasing agreement for Gastrointestinal Endoscopy Products with Premier, Inc. Effective February 1, 2025, the agreement allows Premier members to access special pricing and terms pre-negotiated for Small Bowel Video Capsule Endoscopy products. Premier is a leading technology-driven healthcare improvement company providing solutions to two-thirds of all healthcare providers in the U.S.
- GastroGPO (Specialty Networks)corePartnership with GastroGPO, a Specialty Networks Company, enables GastroGPO members to offer sedation-free, minimally invasive diagnostic tests to visualize the esophagus and stomach using the NaviCam MCCE System. Specialty Networks leverages proprietary patient identification, engagement, and retention technology platform representing over 11,000 providers across gastroenterology, urology, and rheumatology.
- Specialty Networks, LLCcoreSpecialty Networks is a portfolio company of Linden Capital Partners that drives clinical and economic value for independent specialty physician practices through technology and technology-enabled solutions. With over 11,000 providers in gastroenterology, urology, and rheumatology, Specialty Networks provides GPOs, Life Sciences, and Research solutions including patient population health management, patient engagement, clinical research, and workflow automation technologies.
Scale indicators5 records
Recent moves7 records
Expansion highlights6 records
AnX Robotica competitors and assessment
Company assessmentDirect peers
- Medtronic: Medtronic owns the PillCam franchise, the dominant small bowel capsule endoscopy platform globally. It is AnX Robotica's principal direct competitor in small bowel VCE and the predecessor supplier (via SmartPill) in the motility space MotiliCap now targets.
- CapsoVision: CapsoVision offers the CapsoCam Plus, a 360-degree panoramic small bowel capsule endoscope. It is a direct capsule endoscopy competitor targeting the same gastroenterology customer base with an alternative capsule architecture.
Broad incumbents
- Olympus Corporation: Olympus is the global leader in conventional flexible endoscopy systems and serves the same gastroenterology customer base AnX targets. While not a capsule endoscopy specialist, Olympus competes for the same hospital capital budgets and procedure volumes AnX seeks to redirect toward sedation-free capsule diagnostics.
- Fujifilm Healthcare: Fujifilm manufactures endoscopy systems and related GI imaging solutions, competing broadly with AnX in gastrointestinal diagnostics. Its established sales channel and breadth of GI imaging products position it as a broad incumbent competing for hospital and ASC contracts.
- Pentax Medical (HOYA): Pentax Medical produces flexible endoscopy systems and GI imaging solutions sold to gastroenterologists and hospitals. As a broad incumbent with a large installed base, it competes with AnX for GI procedure volume and capital purchasing decisions.
- Boston Scientific: Boston Scientific operates broadly across GI endoscopy (including the former EndoChoice franchise) and is a relevant comparator as a large diversified medtech player with overlapping customer relationships in gastroenterology and ambulatory surgery centers.
Emerging players
- IntroMedic: IntroMedic (South Korea) manufactures the MiroCam capsule endoscopy system and other GI imaging devices. It competes with AnX in the small bowel capsule segment and is a relevant emerging international peer, particularly in Asian markets.
- Jinshan Science & Technology (Chongqing): Jinshan manufactures the OMOM capsule endoscopy system and other GI devices in China. It is a regional/emerging competitor in capsule endoscopy, with growing international presence and overlapping magnetically-controlled capsule development programs.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks5 records
Key highlights7 records
Customer concentration
AnX Robotica social profiles
Digital presenceAnX Robotica financial estimates
Financial estimateRevenue estimate
Valuation estimate
AnX Robotica leadership team
Management profileNumber of profiles
Profiles6 records
AnX Robotica funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
AnX Robotica M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about AnX Robotica
What does AnX Robotica do?
AnX Robotica designs, manufactures, and commercializes magnetically controlled capsule endoscopy systems, AI-assisted diagnostic software, and single-use GI capsules that enable non-invasive, sedation-free visualization of the esophagus, stomach, small bowel, and colon. Its NaviCam platform combines proprietary magnetic-control hardware, deep learning image analysis (ProScan), and clinical software (ESView, MotiliScan) to deliver complete gastrointestinal diagnostic workflows to gastroenterologists, hospitals, and ambulatory surgery centers. The company also sells disposable capsules and radiopaque markers (IntraMarX) that drive recurring consumable revenue.
Is AnX Robotica a public or private company?
AnX Robotica is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was AnX Robotica founded?
AnX Robotica was founded in 2019. It employs 11 to 50 people.
Where is AnX Robotica based?
AnX Robotica is headquartered in Plano, United States, in the North America region.
How does AnX Robotica make money?
Three revenue lines are on record. Capsule Endoscopy Systems are the primary driver. The others are disposable Capsules and software Subscriptions.
Who are AnX Robotica's main competitors?
Direct peers on record are Medtronic and CapsoVision. Broad incumbents are Olympus Corporation, Fujifilm Healthcare, Pentax Medical (HOYA) and Boston Scientific. Emerging players are IntroMedic and Jinshan Science & Technology (Chongqing).
Does AnX Robotica have an API?
No public API is recorded for AnX Robotica.
What industry is AnX Robotica in?
AnX Robotica's product category is Medical Devices - Capsule Endoscopy Systems. Its primary akta.pro industry code is HLAHADAB, Endoscopy Systems & Accessories (Scopes, Cameras, Light Sources, Insufflation). Its NAICS code is 339112 and its SIC code is 3841.